| Name: |
Dr. Ben Williger |
| Designation: |
CEO |
| Country: |
Israel |
| Address: |
- |
| Tel: |
- |
| Mobile: |
+972 52 5569300 |
| Fax: |
+972 4 6564129 |
| E-mail:
|
info@capsutech.com |
| Website: |
http://www.capsutech.com |
| Technology
Classification: |
Biotechnology |
| Main
Business Activity: |
- |
Company
Profile, Products & Technologies, Target Market
CapsuTech is focused on the R&D of polymeric platforms for encapsulation and drug targeting.
These new
molecules are non-toxic with a wide range of applications including
targeted drug delivery and on-site controlled drug release.
CapsuTech’s molecules also provide improved solubility, improved
stability, and reduced drug degradation under exposure to damaging
processes. Finally, CapsuTech’s polymers can be
rationally-designed and manipulated according to needs and can also be
adjusted to various medical and pharmaceutical tasks.
CapsuTech has demonstrated its encapsulation capacity with several
polymeric targeting vehicles and various guest molecules.
Furthermore, in recent studies, CapsuTech has successfully accomplished
toxicity experiments in animal model, and in Proof of Concept
experiments it has demonstrated the targeting capacity of its vehicles
in in vitro models.
Brief
description of proposed R&D project:
Improving solubility of guest molecules, encapsulation, and drug targeting and drug delivery.
Desired
Profile of R&D Partner and its role in the proposed R&D
project:
Pharmaceutical or chemical company interested in improved encapsulation and drug targeting.
|